Welcome to
The Menges Group
Our projects support the evolution of coordinated care programs that improve the quality of life and lower expenditures for high-need Medicaid and Medicare beneficiaries.
What We Do
- Business Development Strategy and Proposal Support
- Data Analytics and Products
- Operational Support for Managed Care Optimization
- Public Policy Analyses
Business Development Strategy and Proposal Support
The Menges Group helps our clients win state Medicaid procurements, meaning we help our clients exist. We assist with several procurements annually, and the majority of our clients not only earn a contract award, they score first or second.
Learn More About This ServiceData Analytics and Products
The Menges Group assists organizations in making optimal use of their own data, and invest heavily in developing our own data sets to support client work. We work with our clients to quantify and track health disparities, identify accomplishments and improvement opportunities, evaluate prior initiatives, and to better target care coordination activities. We help put MCOs’ existing data to optimal use and help strengthen their data capture capabilities in areas such as social determinants of health.
Our in-house databases consolidate information on MCO quality and financial performance, Medicaid prescription drug usage and costs, and Medicaid enrollment.
Learn More About This ServiceOperational Support for Managed Care Optimization
The Menges Group delivers operational support to MCOs including project management, program design and implementation, and interim staffing. Our in-house team is augmented by dozens of specialized experts, many of whom have served in executive roles at MCOs.
Learn More About This ServicePublic Policy Analyses
The Menges Group is committed to contributing to sound, data-driven health policy decisions. We provide unbiased policy analysis support and develop relevant reports for a variety of clients using our quantitative and qualitative databases.
Learn More About This ServiceOur Team
5-Slide Series
Recent Publications
Value of Managed Care Organizations and Pharmacy Benefit Managers in Managing the Medicaid Prescription Drug Benefit
PCMA engaged The Menges Group to estimate the financial and programmatic value of managing the prescription drug benefit in the Medicaid managed care setting, comparing states that utilize MCOs – who contract with PBMs – for their prescription drug benefits to states that manage their prescription drug benefits in…Assessment of Medi-Cal Pharmacy Benefits Policy Options
Policymakers are considering moving Medi-Cal to a pharmacy “carve-out” – that is, shifting the pharmacy benefit out of managed care to instead be administered by the state in fee-for-service (FFS). The carve-out proposal is motivated, in part, by the potential for the state to collect more drug manufacturer rebates….Assessment of Pennsylvania’s Medicaid Preferred Drug List Policy Options
The Pennsylvania Coalition of Medical Assistance MCOs engaged The Menges Group to estimate the fiscal impacts of switching to a uniform PDL in Pennsylvania and to assess the programmatic advantages and disadvantages of this policy change. Our analyses indicate that the Commonwealth of Pennsylvania and its taxpayers would incur…Value of Managed Care Organizations and Pharmacy Benefit Managers in Managing the Medicaid Prescription Drug Benefit
PCMA engaged The Menges Group to estimate the financial and programmatic value of managing the prescription drug benefit in the Medicaid managed care setting, comparing states that utilize MCOs – who contract with PBMs – for their prescription drug benefits to states that manage their prescription drug benefits in…Assessment of Medi-Cal Pharmacy Benefits Policy Options
Policymakers are considering moving Medi-Cal to a pharmacy “carve-out” – that is, shifting the pharmacy benefit out of managed care to instead be administered by the state in fee-for-service (FFS). The carve-out proposal is motivated, in part, by the potential for the state to collect more drug manufacturer rebates….Assessment of Pennsylvania’s Medicaid Preferred Drug List Policy Options
The Pennsylvania Coalition of Medical Assistance MCOs engaged The Menges Group to estimate the fiscal impacts of switching to a uniform PDL in Pennsylvania and to assess the programmatic advantages and disadvantages of this policy change. Our analyses indicate that the Commonwealth of Pennsylvania and its taxpayers would incur…Interested In Learning How The Menges Group Can Help?
Please complete the form on this page.
Someone from our team will promptly respond back to your inquiry!